Blinatumomab…Past, Present, and Future

Description

Title: Blinatumomab…Past, Present, and Future

Presented By: Karen Kestenbaum, DNP, APN, CPHON

Overview of the Course: Presented at the 2025 Spring Education Exchange (SEE), Blinatumomab, a bispecific T-cell engager (BITE), is a targeted immunotherapy used in treating pediatric B-cell acute lymphoblastic leukemia (ALL). With its indications recently expanding, more children are now receiving this innovative treatment. Blinatumomab presents unique side effects and requires specific administration protocols. As frontline caregivers, nurses must be equipped with knowledge about its special considerations, potential adverse reactions, and appropriate treatment strategies. Blinatumomab is becoming increasingly prevalent—where will it appear next? This session is designed to ensure you are prepared for Blinatumomab’s evolving role in pediatric care.

This Session will explore:

• Mechanism of action of Blinatumomab and its role as a bispecific T-cell engager
• Current indications and emerging uses in pediatric B-cell ALL treatment
• Administration protocols and infusion considerations for safe delivery
• Unique side effects and how they differ from other immunotherapies
• Monitoring strategies for early detection and management of adverse reactions
• Supportive care approaches to optimize patient outcomes
• Future directions for Blinatumomab in pediatric oncology

This contains 2 sections:

1. Video Presentation
2. Post-Session Evaluation

Upon successful completion of this course, nurses will earn .50 NCPD. There are .50 pharmacology hours associated with this activity

Association for Pediatric Hematology Oncology Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Provider approved by the California Board of Registered Nursing, Provider Number 14513. Individual Learning Needs Assessment (ILNA) Coding The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. You may claim .50 NCPD in one of the following ILNA categories: Care of the Pediatric Hem/Onc Patient OR Supportive Care, Palliative Care and Symptom Mgt OR Pediatric Oncologic and Hematologic Emergencies OR Pediatric Hem/Onc Nursing Practice OR Treatment OR Foundations of Transplant OR Transplant Process and Infusion OR Cellular Collection, Prep Regimen and Infusion OR Early Post Transplant Management and Education OR Late Post Transplant Management and Education OR  Quality of Life OR Professional Performance

Please reach out to the Education Team at education@aphon.org with your name, the email associated with your APHON account, and the above ILNA category you would like to have reflected on your certificate and APHON can update your completion certificate to reflect your choice.

Any questions? Contact education@aphon.org